AMDI Submits Groundbreaking Dual 510(k) and CLIA Waiver Application to FDA #FDA_Submission #AMDI #Fast_PCR_Mini
0
0
0
0
AMDI Submits Groundbreaking Dual 510(k) and CLIA Waiver Application to FDA #FDA_Submission #AMDI #Fast_PCR_Mini
AliveDx Takes Significant Steps with FDA Submission for MosaiQ AiPlex® Vasculitis Assay #USA #AliveDx #Eysins #MosaiQ_AiPlex #FDA_Submission